Pamidronate active pharmaceutical ingredient is a medication used in the management and treatment of moderate or severe hypercalcemia of malignancy, moderate to severe Paget disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma. It is in the bisphosphonate class of medications.